Proteins from formalin-fixed paraffin-embedded prostate cancer sections that predict the risk of metastatic disease
Open Access
- 16 September 2015
- journal article
- research article
- Published by Springer Nature in Clinical Proteomics
- Vol. 12 (1) , 1-10
Abstract
Prostate cancer is the most frequently diagnosed cancer in men and the third leading cause of cancer related deaths among men living in developed countries. Biomarkers that predict disease outcome at the time of initial diagnosis would substantially aid disease management. Proteins extracted from formalin-fixed paraffin-embedded tissue were identified using nanoflow liquid chromatography-MALDI MS/MS or after separation by one- or two-dimensional electrophoresis. The proteomics data have been deposited to the ProteomeXchange with identifier PXD000963. A list of potential biomarker candidates, based on proposed associations with prostate cancer, was derived from the 320 identified proteins. Candidate biomarkers were then examined by multiplexed Western blotting of archival specimens from men with premetastatic disease and subsequent disease outcome data. Annexin A2 provided the best prediction of risk of metastatic disease (log-rank Chi squared p = 0. 025). A tumor/control tissue >2-fold relative abundance increase predicted early biochemical failure, while <2-fold change predicted late or no biochemical failure. This study confirms the potential for use of archival FFPE specimens in the search for prognostic biomarkers for prostate cancer and suggests that annexin A2 abundance in diagnostic biopsies is predictive for metastatic potential. Protein profiling each cancer may lead to an overall reduction in mortality from metastatic prostate cancer as well as reduced treatment associated morbidity.Keywords
This publication has 41 references indexed in Scilit:
- Identification and Validation of Potential New Biomarkers for Prostate Cancer Diagnosis and Prognosis Using 2D-DIGE and MSBioMed Research International, 2015
- Application of Selected Reaction Monitoring for Multiplex Quantification of Clinically Validated Biomarkers in Formalin-Fixed, Paraffin-Embedded Tumor TissueThe Journal of Molecular Diagnostics, 2013
- Metabolic proteomics of the liver and mammary gland during lactationJournal of Proteomics, 2012
- Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trialThe Lancet Oncology, 2011
- Quantitative Proteomic Profiling of Prostate Cancer Reveals a Role for miR-128 in Prostate CancerMolecular & Cellular Proteomics, 2010
- Generation of high‐quality protein extracts from formalin‐fixed, paraffin‐embedded tissuesProteomics, 2009
- The Paragon Algorithm, a Next Generation Search Engine That Uses Sequence Temperature Values and Feature Probabilities to Identify Peptides from Tandem Mass SpectraMolecular & Cellular Proteomics, 2007
- Characterization of ZAG protein expression in prostate cancer using a semi-automated microscope systemThe Prostate, 2006
- Annexin II and Bleeding in Acute Promyelocytic LeukemiaNew England Journal of Medicine, 1999
- Interaction of the Fibrinolytic Receptor, Annexin II, with the Endothelial Cell SurfaceJournal of Biological Chemistry, 1996